Glassman Wealth Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-37
Closed -$9K 2070
2022
Q3
$9K Buy
37
+5
+16% +$1.35K ﹤0.01% 849
2022
Q2
$8K Buy
32
+2
+7% +$540 ﹤0.01% 887
2022
Q1
$10K Buy
30
+8
+36% +$2.46K ﹤0.01% 842
2021
Q4
$8K Buy
22
+1
+5% +$338 ﹤0.01% 883
2021
Q3
$7K Buy
21
+6
+40% +$2.03K ﹤0.01% 885
2021
Q2
$5K Sell
15
-1
-6% -$307 ﹤0.01% 953
2021
Q1
$5K Buy
16
+3
+23% +$960 ﹤0.01% 892
2020
Q4
$4K Hold
13
﹤0.01% 936
2020
Q3
$4K Hold
13
﹤0.01% 866
2020
Q2
$3K Hold
13
﹤0.01% 801
2020
Q1
$2K Buy
+13
New +$2.16K ﹤0.01% 776

Other funds holding ABMD

Glassman Wealth Services's ABMD Position: Q4 2022 in Review

Glassman Wealth Services sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 37 shares — an estimated $9K sold.

Glassman Wealth Services first reported a position in ABMD in Q1 2020 and held it in 11 quarters. The position peaked at $10K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Glassman Wealth Services reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 37 Abiomed Inc shares in Q4 2022, an estimated $9K.
  • Glassman Wealth Services first reported a position in Abiomed Inc in Q1 2020 and held it in 11 quarters.
  • Glassman Wealth Services's Abiomed Inc position peaked at $10K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Glassman Wealth Services's 13F filing for Q4 2022, filed 6 Feb 2023.